Skip to main content

Table 2 Results for the sensitivity, specificity, and predictive agreement characterizationsa of the S-CRISPR for the identification of the SARS-CoV-2 N gene

From: Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples

 

Sensitivity [95% CI]

Specificity [95% CI]

PPA [95% CI]

NPA [95% CI]

S-CRISPR

87.50% (66.54–96.72)

100% (94.79–100)

100% (80.76–100)

96.70% (89.99–99.15)

  1. aValues were calculated from 112 samples for clinical validation and compared with those of RT-qPCR
  2. CI confidence interval
Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us